Score Overview
See the full market ranking โ
Marker Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 466.79K to $ 3M and net income went from -$ 28M to -$ 12M. Revenue increased in 3 of those 5 years; net income in 2.
Marker Therapeutics Inc currently holds a 5-year HDB Score of 5.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.16 | โ |
1 Year2025-08-12 | $ 1.28 | -9.38% |
5 Years2021-08-12 | $ 19.80 | -94.14% |
10 Years2016-08-12 | $ 63.60 | -98.18% |
20 Years2006-08-11 | $ 33K | -100.00% |
All Time2014-03-25 | $ 582.00 | -99.80% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2014-03-25 |
|---|---|---|---|---|---|---|
| Price | $ 1.16 | $ 1.28 | $ 19.80 | $ 63.60 | $ 33K | $ 582.00 |
| Return | โ | -9.38% | -94.14% | -98.18% | -100.00% | -99.80% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 3M | -$ 12M | $ 16.06T |
| 2024 | $ 6M | -$ 10M | $ 19M |
| 2023 | $ 3M | -$ 8M | $ 15M |
| 2022 | $ 3M | -$ 29M | $ 11M |
| 2021 | $ 1M | -$ 41M | $ 42M |
| 2020 | $ 466.79K | -$ 28M | $ 21M |
| 2019 | $ 213.19K | -$ 21M | $ 43M |
| 2018 | $ 205.99K | -$ 147M | $ 61M |
| 2017 | $ 183.06K | -$ 10M | $ 5M |
| 2016 | $ 0.00 | -$ 2M | $ 7M |
| 2015 | $ 0.00 | -$ 34M | $ 6M |
| IPO2014 | $ 0.00 | -$ 30M | $ 141.94K |
Explore beyond MRKR
You're looking at Marker Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Bausch Health Companies IncBHCยท revenue grew in 80% of years
- Aytu BioScience IncAYTUยท revenue grew in 60% of years
- Quest Diagnostics IncorporatedDGXยท revenue grew in 60% of years
- Takeda Pharmaceutical Co Ltd ADRTAKยท revenue grew in 80% of years
- PTC Therapeutics IncPTCTยท revenue grew in 60% of years
